Zantac (Ranitidine): Patient Information for Australia
1. Basic Product Information
| Active Ingredient (INN) | Ranitidine Hydrochloride |
|---|---|
| Common Australia Brand Names | Zantac, Zantac Relief, Ranitidine Sandoz, APO-Ranitidine |
| ATC Code | A02BA02 |
| Available Forms & Strengths | Tablets: 150 mg, 300 mg Effervescent Tablets: 150 mg Oral Solution: 75 mg/5 mL Injectable/IV solution: 50 mg/2 mL (hospital use) |
| Manufacturers | Sanofi-Aventis Australia, Sandoz Australia, Apotex Pty Ltd and others |
| Prescription Status | Prescription only after 2020 TGA review. Not available OTC due to safety reviews regarding potential impurities (NDMA). Consult your doctor or pharmacist for current legal status and supply options. |
2. Mechanism of Action
In simple terms:
Ranitidine (Zantac) reduces the amount of acid your stomach produces. It works by blocking histamine H2-receptors on the stomach lining, which are signals that normally tell your stomach to make more acid. By reducing acid, it helps prevent symptoms and damage caused by acidity, such as heartburn, indigestion, and stomach ulcers.
For specialists:
Ranitidine is a selective, competitive antagonist of histamine H2-receptors on gastric parietal cells. It inhibits both basal and stimulated gastric acid secretion, including that triggered by histamine, food, or vagal stimulation, without affecting acetylcholine or gastrin pathways.
3. Pharmacokinetics
- Absorption: Rapidly and almost completely absorbed after oral administration. Peak plasma levels reached within 1–3 hours.
- Bioavailability: Approx. 50% due to first-pass metabolism.
- Distribution: Widely distributed (Vd ~1.4 L/kg), low plasma protein binding (15%). Crosses the placenta and appears in breast milk (use with caution during pregnancy and lactation).
- Metabolism: Liver via demethylation, oxidation, and conjugation.
- Elimination: 60–70% excreted unchanged by the kidneys. Elimination half-life is 2–3 hours.
- Duration of Action: Acid suppression lasts 10–12 hours per dose (dose-dependent).
4. Use in Everyday Life and Best Practices
Ranitidine was widely used in Australia for:
- Relief from heartburn and indigestion
- Treatment and prevention of gastric & duodenal ulcers
- Treatment of gastro-oesophageal reflux disease (GORD/GERD)
- Prevention of acid-related injury in chronic NSAID use
- Adults: 150 mg twice daily or 300 mg once daily (evening)
- Dosage and duration depend on indication and doctor's instructions
- Swallow tablets whole with water; do not crush unless advised
- Effervescent tablets: dissolve in water before use
- Take exactly as prescribed, ideally at the same times each day
5. Dosing in the Morning vs Evening
- Morning dosing: May help if symptoms occur after breakfast or throughout the day.
- Evening dosing: Taking ranitidine at bedtime is effective for preventing overnight acid secretion and managing nocturnal symptoms, which are common in GORD/ulcer patients.
- Best practice: Take at the same time(s) each day. For severe cases, you might be prescribed twice-daily dosing (morning and evening).
- Consistency: Regular dosing improves results. Avoid missing doses—if forgotten, take it as soon as you remember, unless it is almost time for the next dose.
6. Taking With Food or on an Empty Stomach
- Ranitidine can be taken with or without food. Food does not significantly affect absorption or efficacy.
- Taking after meals may help with heartburn relief common in the English diet (including rich meals, spicy foods, or late-night suppers).
- Avoid alcohol and excessive fatty or spicy foods, as these may exacerbate symptoms.
7. Interaction Warnings
| Type | Examples | Advice |
|---|---|---|
| Food | Rich, fatty, or spicy meals; alcohol | May worsen reflux/heartburn symptoms |
| Alcohol | Beer, wine, spirits | Can increase gastric irritation; limit intake |
| Medications | Antacids (wait 1-2 hrs before/after), ketoconazole, atazanavir, procainamide, warfarin, theophylline, glipizide, midazolam | Check with doctor/pharmacist: may alter absorption or side effects |
| Other | Cigarette smoking | May lower ranitidine efficacy |
8. Indications (Official & Off-Label)
| Indication | Status | Notes |
|---|---|---|
| Treatment of peptic/gastric and duodenal ulcers | Official | Short and long-term use |
| Gastro-oesophageal reflux disease (GORD/GERD) | Official | For symptomatic relief and healing |
| Zollinger-Ellison syndrome | Official | For hypersecretory states |
| Prevention of NSAID-induced ulcers | Official | For chronic NSAID therapy |
| Functional dyspepsia | Off-label | Symptomatic management (less common) |
| Stress ulcer prophylaxis (ICU/Hospital) | Official/Off-label | Hospital protocols |
| Pediatric use (reflux, peptic ulcers) | Off-label | Specialist/paediatrician guidance only |
9. Dosing According to Clinical Indications
| Indication | Adult Dose | Pediatric Dose | Elderly / Renal Dose |
|---|---|---|---|
| Gastric/duodenal ulcers | 150 mg twice daily or 300 mg once at night (4-8 weeks) | 2-4 mg/kg twice daily (max 300 mg/day) | Reduce dose if creatinine clearance <50 mL/min |
| GORD | 150 mg twice daily or 300 mg once at night | 2-4 mg/kg twice daily | Adjust as above |
| Prevention of NSAID ulcers | 150 mg twice daily throughout NSAID therapy | Not routine | Adjust as above |
| Zollinger-Ellison | 150 mg three times daily (titrate as needed) | Specialist only | Adjust as above |
| Stress ulcer prophylaxis (IV) | 50 mg IV every 6–8 hrs | Per protocol | Monitor renal function |
10. Safety Profile & Side Effects
| Frequency | Side Effects | Warnings |
|---|---|---|
| Common (1–10%) | Headache, diarrhoea, constipation, abdominal discomfort, dizziness, rash | Usually mild; consult doctor for persistent symptoms |
| Uncommon (~1%) | Fatigue, confusion (elderly), bradycardia, muscle/joint pain | Risk higher in elderly/severely ill |
| Rare (<0.1%) | Hepatitis, pancreatitis, blood count disorders, Allergic reactions (swelling, difficulty breathing), Stevens-Johnson Syndrome | Discontinue and seek medical attention |
| Warnings | Risk of contamination with NDMA (potential carcinogen) has led to regulatory review and restrictions | Consult doctor immediately if jaundice, severe skin rash, or dark urine |
Special safety considerations: Long-term use is discouraged unless clearly indicated. Monitor for liver or kidney function in at-risk groups.
11. Guidelines for Proper Use (Australia Context)
- Strictly follow your doctor’s or pharmacist’s instructions—do not adjust the dose yourself.
- Keep regular follow-up appointments, especially for long-term use.
- If symptoms persist/worsen or if new symptoms develop (e.g., weight loss, vomiting), see a doctor promptly.
- Alert your healthcare provider to any allergies, liver, or kidney conditions before starting.
- Ask your pharmacist for a medicines list/review to check for interactions with other prescription or over-the-counter medicines.
- Do not stop treatment suddenly unless advised.
- Ranitidine is no longer available OTC—do not use any old supplies; obtain new medicine via prescription after medical review.
- Report any side effects (especially jaundice or breathing issues) to the TGA’s Adverse Medicine Events line: 1300 134 237.
12. Alternative Treatment Options
- Proton Pump Inhibitors (PPIs):
- Omeprazole, Esomeprazole, Pantoprazole, Lansoprazole: More effective for severe GORD, ulcers. Generally well-tolerated, but long-term use linked to low magnesium, vitamin B12 deficiency, fractures.
- Other H2-receptor antagonists:
- Famotidine, Nizatidine (more stable, rarely affected by NDMA impurity issue; consult for product availability and PBS reimbursement).
- Antacids (e.g., Mylanta, Gaviscon):
- Quick relief, but short acting. Suitable for occasional symptoms (not for ulcers/GORD long-term).
- Alginates:
- Gaviscon Dual Action improves reflux symptoms by forming a raft over stomach acid.
| Option | Pros | Cons |
|---|---|---|
| PPIs (Omeprazole) | Highly effective, strong acid suppression, PBS reimbursed for GORD/ulcers | Possible long-term side effects, strict indication needed |
| Famotidine | Less NDMA risk, good acid suppression | Supply may vary, less data in some populations |
| Antacids | Rapid action, OTC | Short duration, not for chronic management |
| Alginates | Safe, well-tolerated | May not prevent ulcers, for mild symptoms |
13. Legal, Registration, and Reimbursement Status in Australia
- TGA Registration: Ranitidine (Zantac) was registered by the Therapeutic Goods Administration (TGA) but several products were withdrawn from the Australian market in 2020 due to NDMA contamination concerns. Some intravenous forms remain for hospital settings.
- Prescription Status: Prescription only. OTC use not permitted.
- PBS Reimbursement: Ranitidine is not currently listed on the PBS; alternatives (e.g., PPIs, famotidine) are reimbursed—check with your prescriber.
- Supply Chain: Check current stock status and availability with your local pharmacy, as ranitidine may be difficult to source.
14. Latest Research and Clinical Guidance (2022–2025)
- Recent reviews by Australia’s TGA and the FDA (USA) have confirmed that NDMA contamination is a potential carcinogen risk in ranitidine products; this led to widespread recalls and suspension of supplies [TGA Product Alert, 2022].
- Guidelines now recommend the use of proton pump inhibitors or alternative H2-receptor antagonists (such as famotidine) for acid-related conditions.
- A 2024 Lancet meta-analysis confirmed that while ranitidine was as effective as PPIs for mild GORD/ulcer indications, safety concerns outweigh benefits if alternatives are available.
- Patients are advised not to use ranitidine from uncertain sources and to always consult their healthcare provider for current therapeutic options.
15. Availability and Delivery
Availability of ranitidine in Australia is currently limited for regular community use, due to regulatory actions. Hospital use of injectable ranitidine may persist for certain indications. Check with your pharmacist for alternative medicines and supply estimates.
| Form/Pack Size | Indicative Price (AUD) | Delivery Times (Standard) |
|---|---|---|
| Zantac 150 mg x 30 tablets* | $15–$25 | 1–2 business days (Sydney, Melbourne, Brisbane) 2–4 days (Perth, Adelaide, Hobart, Darwin) |
| Zantac 300 mg x 30 tablets* | $22–$35 | As above |
| Ranitidine oral solution* | $20–$30 per 100 mL | 2–4 days (regional/remote) |
| Injectable ampoules (hospital only) | Varies (hospital supply) | N/A |
*Note: Ranitidine supply and sale are subject to current TGA regulations. Check with your local pharmacy for the latest status or approved alternatives.
16. Frequently Asked Questions (FAQ)
Q1. Can I still get Zantac or ranitidine in Australia?A1. Most ranitidine products were withdrawn from community pharmacies in Australia in 2020 by order of the TGA due to impurity concerns. You cannot buy Zantac over the counter. Speak to your doctor about alternative medicines like PPIs or famotidine.
Q2. Are there safe alternatives to ranitidine for reflux or ulcer treatment?
A2. Yes. Proton pump inhibitors (e.g., omeprazole, esomeprazole) and other H2-receptor antagonists (famotidine) are effective and available in Australia. Your doctor will select the best option for your condition.
Q3. What should I do if I have leftover ranitidine or Zantac at home?
A3. Do not use expired or old ranitidine. Return it to your pharmacy for safe disposal. If you need acid-suppressing medication, contact your GP or pharmacist for guidance.
Q4. Can I drink alcohol while taking medicines for heartburn or ulcers?
A4. Alcohol can increase reflux and irritate your stomach lining. Moderate intake is usually acceptable, but avoid drinking if it worsens your symptoms or as advised by your doctor.
Q5. How can I manage heartburn and reflux without medication?
A5. Lifestyle changes can help: eat smaller meals, avoid spicy/fatty foods, stop smoking, raise the head of your bed, maintain a healthy weight, and avoid eating close to bedtime. Consult your doctor for a tailored plan.
This information is designed to support, not replace, the relationship that exists between a patient and their healthcare professionals. Always consult your GP or pharmacist for advice specific to your health needs.
